Anti-CD33 [SGN-33 (Lintuzumab)]
AB00730-10.3-BT
ApplicationsFunctional Assay
Product group Antibodies
ReactivityHuman
TargetCD33
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD33 [SGN-33 (Lintuzumab)]
- Delivery Days Customer9
- Application Supplier NoteIn vitro, this antibody is capable of mediating ADCC against AML cells (Caron, 1998). Though shown to be safe in phase III trials, the use of this antibody in combination with induction chemotherapy did not result in a statistically significant improvement in response rate or survival in patients with refractory/relapsed AML (Feldman, 2005).
- ApplicationsFunctional Assay
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSGN-33 (Lintuzumab)
- Gene ID945
- Target nameCD33
- Target descriptionCD33 molecule
- Target synonymsCD33rSiglec, SIGLEC-3, SIGLEC3, p67, myeloid cell surface antigen CD33, CD33 antigen (gp67), CD33 molecule transcript, gp67, sialic acid-binding Ig-like lectin 3
- HostHuman
- IsotypeIgG1
- Protein IDP20138
- Protein NameMyeloid cell surface antigen CD33
- Scientific DescriptionNOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203





